STOCK TITAN

North Run discloses 9.99% SCND stake via 13G/A amendment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Scientific Industries, Inc. (SCND) received an Amendment No. 4 to Schedule 13G from North Run entities and affiliates reporting beneficial ownership of 1,189,632 shares of common stock, equal to 9.99% of the class.

The reported amount includes 835,000 common shares and 354,632 warrants that are exercisable within 60 days. As of September 30, 2025, the reporting group held an aggregate of 920,000 warrants, but only 354,632 are currently exercisable due to beneficial ownership limitations. The percentage was calculated using 11,553,599 shares outstanding as of August 19, 2025.

The reporting persons have shared voting and dispositive power over the 1,189,632 shares and no sole power. They certified the securities were not acquired for the purpose of changing or influencing control.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



North Run Capital, LP
Signature:/s/ Michael Fisher
Name/Title:Michael Fisher / Attorney-in-Fact for Thomas B. Ellis and Todd B. Hammer, Members of General Partner
Date:11/13/2025
North Run Advisors, LLC
Signature:/s/ Michael Fisher
Name/Title:Michael Fisher / Attorney-in-Fact for Thomas B. Ellis and Todd B. Hammer, Members
Date:11/13/2025
Todd B. Hammer
Signature:/s/ Michael Fisher
Name/Title:Michael Fisher / Attorney-in-Fact
Date:11/13/2025
Thomas B. Ellis
Signature:/s/ Michael Fisher
Name/Title:Michael Fisher / Attorney-in-Fact
Date:11/13/2025
Michael Bosco
Signature:/s/ Michael Fisher
Name/Title:Michael Fisher / Attorney-in-Fact
Date:11/13/2025
North Run - Due North Partners, LP
Signature:/s/ Michael Fisher
Name/Title:Michael Fisher/ Attorney-in-Fact for Thomas B. Ellis, Todd B. Hammer and Michael Bosco Members of General Partner
Date:11/13/2025
North Run GP, LP
Signature:/s/ Michael Fisher
Name/Title:Michael Fisher / Attorney-in-Fact for Thomas B. Ellis and Todd B. Hammer, Members of General Partner
Date:11/13/2025

FAQ

Who filed the Schedule 13G/A for Scientific Industries (SCND)?

North Run Capital, LP; North Run Advisors, LLC; North Run – Due North Partners, LP; North Run GP, LP; and individuals Todd B. Hammer, Thomas B. Ellis, and Michael Bosco.

How many shares do the filers beneficially own in SCND?

They reported 1,189,632 shares beneficially owned, representing 9.99% of the class.

What is the composition of the reported holdings for SCND?

The filing lists 835,000 common shares and 354,632 warrants exercisable within 60 days.

What warrants position is disclosed in the filing?

As of September 30, 2025, they held 920,000 warrants, with 354,632 exercisable within 60 days due to beneficial ownership limits.

What share count was used to calculate the 9.99% stake in SCND?

The calculation used 11,553,599 shares outstanding as of August 19, 2025.

Do the filers have voting and dispositive power over the SCND shares?

Yes, they report shared voting power and shared dispositive power over the 1,189,632 shares; no sole power.

Does the filing indicate an intent to influence control at SCND?

They certified the securities were not acquired for the purpose of changing or influencing control.
Scientific Ind

OTC:SCND

View SCND Stock Overview

SCND Rankings

SCND Latest News

SCND Latest SEC Filings

SCND Stock Data

8.09M
5.37M
Scientific & Technical Instruments
Technology
Link
United States
Bohemia